Sorry, this entry is only available in Ukrainian.
Angelini Pharma виходить на ринок США через придбання Catalyst Pharmaceuticals за $4,1 млрд
Вас может заинтересовать:
WEB only
On July 26, 2023, FDA released a guidance document on a program at FDA’s Center for Drug Evaluation and Research (CDER) to publicize a listing of accepted voluntary consensus standards…
WEB only
The EMA has launched a consultation on the circumstances in which single-arm trials (SATs) – those without a control group – can be used to support marketing applications for medicines…
